16 November 2020 Step up for TB 2020 - Social Media Gallery, Animated Images Each and every one of the 1.4 million deaths caused by TB in 2019 could have been prevented. The #StepUpForTB report analyses policies for tackling TB in 37 high-burden countries.⬇️ https://msfaccess.org/stepupfortb Tweet this Children are especially vulnerable to #tuberculosis. In 2019, 1.2 million children fell sick with TB. Children with TB deserve access to effective treatments free of toxic drugs that have to be injected. https://msfaccess.org/stepupfortb Tweet this It’s time for change. Governments need to ensure that critical innovations in TB treatment, diagnostics and prevention reach the people who need them. Read our report how governments can Step Up for TB! ⬇️ #StepUpForTB https://msfaccess.org/stepupfortb Tweet this ⏲️ ⏲️ It’s time for change. Countries CAN stop deaths from TB. This is achievable if policies are rapidly updated and implemented at scale. Read the report ⬇️ #StepUpForTB https://msfaccess.org/stepupfortb Tweet this Each and every one of the 1.4 million deaths caused by TB in 2019 could have been prevented. The #StepUpForTB report analyses policies for tackling TB in 37 high-burden countries.⬇️ https://msfaccess.org/stepupfortb Tweet this Children are especially vulnerable to #tuberculosis. In 2019, 1.2 million children fell sick with TB. Children with TB deserve access to effective treatments free of toxic drugs that have to be injected. https://msfaccess.org/stepupfortb Tweet this It’s time for change. Governments need to ensure that critical innovations in TB treatment, diagnostics and prevention reach the people who need them. Read our report how governments can Step Up for TB! ⬇️ #StepUpForTB https://msfaccess.org/stepupfortb Tweet this ⏲️ ⏲️ It’s time for change. Countries CAN stop deaths from TB. This is achievable if policies are rapidly updated and implemented at scale. Read the report ⬇️ #StepUpForTB https://msfaccess.org/stepupfortb Tweet this Read, watch, share Filter by - Any -BlogEventsExplainerFact sheetFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Events | 11 August 2005 Tropical & neglected diseases Call to governments: Boost innovation for neglected diseases 1 min Events | 11 August 2005 Tropical & neglected diseases Leishmaniasis: Patient's need driven R&D Agenda Events | 11 August 2005 HIV/AIDS Patient's needs driven Research and Development Agenda Events | 11 August 2005 Tropical & neglected diseases Understanding the medical R&D Treaty Proposal Press release | 02 August 2005 HIV/AIDS Research and development Creative approach allows MSF to treat children with AIDS. But enormous challenges remain. Press release | 26 July 2005 HIV/AIDS Intellectual property and trade Action needed to tackle the second wave of the AIDS drug pricing crisis Press release | 06 July 2005 HIV/AIDS Intellectual property and trade Research and development Tropical & neglected diseases Tuberculosis MSF talking points for the Group of Eight (G8) meeting in Scotland, July 2005 Press release | 28 June 2005 HIV/AIDS Intellectual property and trade Prices of AIDS Medicines in Developing Countries continue to be a concern Load More
Events | 11 August 2005 Tropical & neglected diseases Call to governments: Boost innovation for neglected diseases 1 min
Events | 11 August 2005 Tropical & neglected diseases Leishmaniasis: Patient's need driven R&D Agenda
Press release | 02 August 2005 HIV/AIDS Research and development Creative approach allows MSF to treat children with AIDS. But enormous challenges remain.
Press release | 26 July 2005 HIV/AIDS Intellectual property and trade Action needed to tackle the second wave of the AIDS drug pricing crisis
Press release | 06 July 2005 HIV/AIDS Intellectual property and trade Research and development Tropical & neglected diseases Tuberculosis MSF talking points for the Group of Eight (G8) meeting in Scotland, July 2005
Press release | 28 June 2005 HIV/AIDS Intellectual property and trade Prices of AIDS Medicines in Developing Countries continue to be a concern